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The purpose of this study was to clarify the relation-
ship between the cellular and humoral immune com-
ponents in the pathogenesis of vitiligo vulgaris. By 
using cytokines as indicators of peripheral mononu-
clear cell (MNC) function, we compared the effects of 
phytohemagglutinin (PHA) and purified IgG on 
MNCs derived from patients suffering from active 
vitiligo with those from normal controls. The results 
revealed (i) a significant increase in spontaneous 
production of IL-6 and IL-8 in patients; (ii) PHA, 
purified IgG from patients (IgG-anti-MC), or IgG 
from normal controls (N-IgG) induced a significant 
increase in IL-6 but diminished GM-CSF, TNF-a, and 
IFN-l' release in patients; and (iii) IgG-anti-MC 
brought about a significantly higher stimulatory ef-
fect on IL-l/3 and IFN-l' production than N-IgG in 
F unctional m e lanocytes in p a tien ts with vitiligo vulgari s disapp ear from invol ved skin by a m ech anism(s) th at h as yet to b e identifie d. An immlUlo logic hypo thesis is cu~rently advan c.e.d as a .poss ible pa~h~genes is o.f vi ~i~i ?o. E Viden ce supportmg tlus h ypo theSIS Includes (I) vmhgo 
is o ccasionall y associa te d with certain ,lutoimmune disorders (ZauLi 
et ai, 1986; H egedus el ai , 1 994) , (ii) p resen ce of c ircula tin g 
o rgan- sp ecific au toantibo dies (C unLiffc e/ al; 1968; H a.rso ulas e/ ai, 
197 8; B ette rl e el ai, 1985), (iii ) occurre n ce o f m elan ocyte-sp ecific 
antib o dies (N aug hto n et ai, 1983 a, 1 983 b) , and (iv) ab erration s in 
th e proporti.on o f T - cell subpo pulatio n s (Soubiran eI ai , 1985; 
G rimes et ai, 1986; D 'Am e lio e/ ai, 1 990 ; Mozzanica el (/1 , 1990 ; 
H ann et (/1 , 1.993; Al- Fouz an el ai, 1 995) . Of these, th e presen ce o f 
anti-melanocyte antibo dies and imbal an ce in p e tipheral m o n o nu-
clear cell (MN C ) subsets m ay play p artic ularl y impo r tant ro les in 
th e pathogen esis of vitiligo. A nti-m c lan ocyte a ntibodie~ w ere 
fo und to induce m e lan ocyte damage in vi/ro b y a comple m e n t-
mediated m ech anism and antibody-dep ende nt cellular cyto toxic ity 
(N o rri s et ai, 1988). Although altera tions in MN C subpopula tio n s. 
esp ecially in T lymphocytes, h ave b een th e subj ect o f inte n sive 
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puri fied IgG fro m normal con trols; MNC . mononuclea r cell. 
normal controls. Imluunologically, IL-6 can enhance 
melanocyte ICAM-l expression, which may increase 
leukocy te-n1.elanocyte attachment and cause mela-
nocy te damage in vitiligo. A decrease in GM-CSF (an 
intrinsic growth factor for melanocyte) production 
may retard recovery from vitiligo by checking the 
proliferation of surviving melanocytes. A significant 
decrease in TNF-a and IFN-l' production may par-
tially explain the reduced inflammatory reaction in 
vitiliginous lesions. That I gG-anti-MC stimulates an 
increase in IL-l/3 and IFN-y production in controls 
suggests that IgG-anti-MC may play a role in mela-
nocyte destruction mediated by monocytes. K ey 
lVol'ds: cytokitlelt1itiligo vnlgal'isfIgG atlti-lIIelauocyte anti-
bodies. ] Invest D ev-matol 108:527-529, 1997 
inves tiga tions, o nly a few publ.ication s d ealt w ith c h an ges in MNC 
function in v itiligo patien ts (M ozzanica e/ ai, 1989; A bde l-N ase r 
and L udw ig, 1992; Mozzanica cl ai, 1992; Tah er-Uz- Zam an cl ai, 
1992). In tlli s study the sp o ntaneo us and phytoh em agglu tini.n 
(PHA )- and anti- m elan ocyte antibo d y- stimul ated production of 
cytokin es o n MNCs w ere s tudied to advan ce o ur understanding of 
th e roles o f MNCs in th e pa th ogen esis of vitiligo. 
MATEIUALS AN D METH ODS 
Sele ction of Patients Twelve patients with viti ligo of non-segmentaJ-
type were selected in this study. All patien ts had developcd newly dcp ig-
mcnced lesions within the previous 3 mo; that is, they were suffering from 
acti vc viti ligo (Mocllmaltn e( nl, 1982). None of the paticncs had an y known 
au to inUl11111 C d isorders such as H ashillloto ' s thyroiditis, Grave 's disease, 
pernicious anemia, or insulin-depcndent diabetes melli tus. An equal number 
of age- an d sex-matched hea.l thy individuals served as con trols for the 
prcsent study . None of the parti cipants had received medical treatmcnt in 
the prececding 3 mo . 
Purification of I g G from Serum of Vitiligo Patient s with Anti-
Melanocyte Antibodies Serum fro m patients with active vitiligo 'llld 
no rmal contro ls was co llected for purification . T hc fraction II (lgG) 
o btained fro m Scphacryl S-300 ge l fi ltration was further absorbed into the 
protein A-Sepharosc 4B (Pharmacia LKB. Uppsa la, Sweden). Sepharose-
conjugatcd IgG was clu tcd with soclium acetate bu ffe r at pH 2.5 and 
immcdiately ncutralized to pH 7.2 with 1 N N aOH . After adequate dialysis 
aga inst disti llcd watcr, the IgG was lyophil ized (Yu et nl. 1989a). T he 
pro tein concentration of pur ified IgG was dcrcn11ined by Dio-Rad protein 
assay kit (Bio-R ad, Kichmond. A). 19G preparations were fo und to be free 
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of contaminants by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis on 10% gels (Laemmli, 1970). 
Melanocyte Culture and IgG Anti-Melanocyte Antibody Detection 
Normal adult human foreskin was employed for melanocyte culture. 
Melanocytes were isolated and maintained in culture as described (Kao and 
Yu, 1991). Second-passage cells were used for IgG anti-melanocyte anti-
body (lgG-anti-MC) detection. The individual purified IgG was measured 
for anti-melanocyte activity by cellular enzyme-linked immunosorbent 
assay (ELISA) as reported (Yu ct aI, 1993). Six samples containing the 
highest titer of IgG-anti-MC were tI,en used in the following ex'Veriments. 
Isolation of Peripheral MNCs and Preparation of MNC Superna-
tants Peripheral MNCs were isolated from heparinized venous blood of 
patients and normal individuals by cenrrifuging at 300 X g for 30 min over 
a Fico ll-Hypaque cushion (specific gravity, 1.077) as reported (Yu ef aI, 
1989b). The cell concentration was adjusted to 2 X 10" cells per ml in 100;., 
feta l bovine serum in [lPMI 1640 medium (GIBCO, Gaithersburg, MD) . 
Fifty microHters of MNCs were placed in triplicate microwclls. Tben, 0.02 
mJ of 10% fetal bovine serum in [lPMI 1640 medium (spontaneous), .PI-IA 
(5 J.l.g per ml , Sigma, St. Louis, MO) , IgG-anti-MC (100 J.l.g per ml) or 
normal IgG (N-lgG) (100 J.l.g per ml), and 0.13 ml of 10% fetal bovine 
serum in RPMI 1640 medium was added to the microwells. T he mixture 
was incubated at 37°C in 5% C02 /95% air for 24 h . After incubation, tbe 
mixture was centrifuged at 2000 rpm for 10 min and the cell-free supematants 
were collected and stored at - 20°C until cytokinc detcmlination. 
Measurement of Cytokil1es in MNC Supernatants by ELISA The 
concentra tion of cytokines in the culture supematanrs derived from 1 X 10" 
MN Cs per ml after a 24-b incubation with medium, PHA, IgG-anti-MC, or 
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N-lgG was measured by commercially available ELISA test kits. The ELISA 
ki ts include in terieukin (IL)-l/3, lL-6, IL-8, granulocyte-macrophage col-
ony-stimulating factor (GM-CSF), tumor necrosis factor-a (TNF-a), and 
illterferoll-y (IFN-y) (Research and Develop System, Minneapolis, MN), 
and we followed the manuf.1cturer's instruction. The results were presented 
as mean :!: SD. Unpaired Student's t test was used to analyze the statistical 
differences between patients and controls. A differencc of p < 0.05 was 
cousidered as statistically significant. 
RESULTS 
Anti-Melanocyte Activity of Purified IgG from Active Viti-
ligo Patients Is Significantly Higher Than That from Con-
trols Purifie d IgG from serum of 12 patients w ith active vitiligo 
was assesse d for melanocyte-binding activity by cellular ELISA. By 
u si.ng m e thanol-fixed m e lanocytes as substrate, the optical density 
at 490 nm, a m easure of purified IgG, was sig nificantly higher fo r 
vitiligo patients (0 .70 ± 0.16) than for tb e controls (0 .25 :!: 0.14) 
(p < 0 .05, Fig 1). 
A Significant Increase in Spontaneous Production of IL-6 
and IL-8 in Patients with Active Vitiligo T he spontaneous 
release ofIL-6 and IL-8 was significantly highe r in patients than in 
healthy controls (IL-6 , 150.6 ± 32.5 pg per m1 VS. 104.7 ± 15 .9 pg 
per ml; IL-8, 1412.2 ± 857.7 pg per ml VS. 198.7 ± 31.6 pg per ml; 
p < 0.05). In contrast, di1feren ces in the sp o ntaneous IL-1 /3, 
GM-CSF, TNF-a, and IFN-)' release were not sig nificant (Table 
I). 
PHA, IgG-anti-MC, and N-IgG Indnced a Higher IL-6 
Production but Lower GM-CSF, TNF-a, and IFN-y Release 
in the Patient Group as Compared with the Control Group 
As demonstrate d in Table I , PHA, IgG-anti-MC, or N-IgG 
induced a significant increase in IL-6 production , and a decrease in 
GM-CSF, TNF-a, and IFN-)' release were found in patients with 
active vi tiligo as compare d with controls. Moreover, IgG-anti-MC 
induced signifIcantly highe r IL-1/3 produ ction in contro ls than in 
patients (p < 0.05). PHA- or N-IgG- stimulated IL-1/3 production 
was similar b etween patients and normal controls. A n additional 
ulteresting finding was that IgG-a nti-MC in con trols had a signif-
icantly highe r stimulatOl'Y eff:ect o n IL-l/3 (p < 0.005) and fFN-)' 
(p < 0 .05) production tban did N-IgG. 
DISCUSSION 
M elanocytic cytoto xicity of immune mechanism s in vitiligo is a 
complex process ulVolving e ffector-target attachment v ia pairs of 
adhesive m olecttles, activation of le ukocyte receptors by tar get 
antigens and other cell-surfuce m arke rs, and triggering of cytolysis 
(Martz, 1987; Norris, 1990; Morelli and Norris , 1993) . AI Badri el 
at (1 993) reported increased el'.'Pressio n of inte rceJluiar adhesion 
Table I. PHA, IgG-anti-MC, N-IgG Induced Higher IL-6 Production but Lower GM-CSF, TNF-a, and IFN-y Release in 
the Patient Group (Pt) Compared to Controls (NC)" 
Cytokinc 
(pg/ ml) 
IL-l/3 
IL- 6 
fL-8 
GM-CSF 
T NF-a 
IFN-y 
N = 12 
NC 
Pt 
NC 
Pt 
NC 
Pt 
NC 
Pt 
N C 
Pt 
NC 
Pt 
Spontaneous 
R.clease 
88 .7 :!: 16.3" 
94.8 :!: 18.1 
104.7 :!: 15.9' 
150 .6 :!: 32.5 
198.7 :!: 31.6" 
1412.2 :!: 857.7 
23 .6 :!: 51.6 
33.4 :!: 10.1 
20.1 :': 51.1 
37.4 :': 29 .9 
54.3 :!: 7.5 
73.9 :!: 27.0 
PHA IgG-anti-MC N-lgG 
(5 J.l.g per mJ) (100 J.l.g pcr ml) (100 g per 1111) 
657.2 :!: 6.2 1054 .6 :!: 105.3' 792 .3 :': 145 .9-' 
673.8 :!: 91.9 915.4 :!: 134.0 756.1 :!: 142.1-' 
572.1 :': 385.3" 809.2 :!: 251.4' 827.8 :!: 142.3' 
1275.6 :!: 427.8 1225.6 :!: 288.4 1068.3 :!: 231.5 
5818.7 :!: 1531.7 6621.7 :!: 1570.2 6144.2 :!: 1308.6 
6397. 1 :!: 1777.7 7104.9 :!: 2303.4 6696 .0 :!: 1932.3 
1293.7 :': 97.4< 1269.4 :!: 104.3" 1446.9 :!: 212.7< 
118.9 :!: 84 .8 11 5.0 :!: 75.0 141.2 :!: 105.7 
1212.5 :!: 502.9" 1255.0 :!: 668.3 ' 1186.4 :!: 541.3 ' 
29 'l.1 :!: 137.5 268.5 :!: 126.3 254.8 :!: 127.6 
592.1 :!: 66.3" 964.1 :!: 117.5" 651.5 :': 1 05 . 8~f 
249.0 :!: 108.6 267.4 :!: 64 .9 264 .2 :!: 110.3 
( I The monol1uclear cells ('1 X 106 cells per 1111) o bta ined from patients with active vitiHgo and trom controls were incubated with medium (spo ntaneolls rclc:\sc). PHA. 
JgG-anti-MC pu ri fied frol11 active viti ligo, or N-lgG OI t 37D C for 24 h. The cc U-fi'cc slI pcnla tan ts were measured for respective cyrokincs by ELI SA kit. 
I, VaJuc denotes mean ± SD. r p < 0.05 ; .J p < 0.01; ,. p < 0.00'1, when comparing controls with patients; .r p < 0.05; ,I: P < 0.005, w hen comparing cot1ll'ols stil1l uln tcd with 
IgG-anti-MC or N-lgG (using unpaired Student's t tcst). 
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molecule 1 (rCAM- l) on melanocytes in active vitiligo lesions. 
ICAM- 1 is necessary for leukocyte-melanocyte attachment that 
develops in to immuno logic cytotoxicity (Morelli and N OI:riS, 
1993). M any cytokines such as IFN -y, T N F- a, T N F-,B, IL-1, IL-6, 
and lL-7 can induce the expression o f cell surface ICAM-1 o n 
melan ocytes (Yohn et aI, 1990, Ki rnbauer el al, 1992) . In this study, 
IL-6 production ofMN Cs was fo und to be significantly increased in 
pa tients with vitiligo. It is not inconceivable that this cytokine not 
only enhances m elanocyte lCAM-l expressio n , w hich m ay trigger 
leukocyte-melanocyte attachmen ts, but also induces polyclonal 
B-cell activa tion , increasing autoantibody production and causing 
melanocyte dam age in vitiligo. In addi tion , increased IL- 8 produc-
tion by patients activa ted monocytes may be able to attract polymor-
phonuclear neutrophils (Yoshimura et aI, 1987) and T lymphocytes 
(Larsen et ai, 1989) to the sites of lesions, amplifYin g inflammatory 
reactions and, therefore, facilitating melan ocytic cytotoxicity. 
Ano ther interes ting fi nding in this study is a decrease in the 
production of GM-C SF, T N F- a, and IFN-y by MN Cs in patients 
wi th active vitiligo . GM-CSF had been reported as an intrinsic 
fac to r for m elanocyte growth (lmokawa et aI, 1996) . A signifi can t 
decrease in GM-CSF release in active vitiligo m ay retard the 
prolife ration o f surviving melanocytes and reco very from vi tiligo . 
TNF- a has been implicated as a fund am ental inflammatory m edi-
ator (Vlassa ra et aI , 1988; Tracey et aI, 1989) and IFN-y as an 
immuno modulator (Trin chieri et aI, 1985). A signifi can t decrease in 
TNF- a and IFN-y production by m o nonuclear cells in active 
v itiligo may partially expl ain the reduced inflammatory reaction and 
~ell infiltrati on (Moellillann et aI, 1982; Kao and Yu, 1990) in 
lesions. 
By using cultured melanocytes as a substrate, cellular ELISA 
revealed a higher optical density for IgG-an ti-MC as compared to 
N-IgG. On the other hand, IgG-an ti -MC and N-IgG exllibited a 
poten t stimulato ry effect 0 11 cy tokine production by MNCs both in 
patients with ac tive vitiligo and in normal individu als. T his may 
indicate th at MNCs per se are not the uniqu e tar get cell s for 
IgG-anti-M C. IgG- anti-M C, however, had a significantly higher 
stimulatory effect on IL-l,B and IFN -y production than did N-rgG 
in n ormal con tro ls. Since IFN - y stimulates IL-l ,B production by 
monocytes and major histocompatibility complex class r and class II 
expression on m any cells, IgG-anti-MC m ay play a role in the 
inflammatory and immuno logic processes of m elanocyte destruc-
tion m ediated by monocytes . 
An increase in the production o f proin fl ammatory cytokines, th at 
is, IL- 6 and IL- 8, by the MNCs of active vitiligo patients m ay play 
an impo rtan t role in m elanocytic cytotoxicity thro ugh the enhan ce-
ment of e ffector cell migration and e ffectOl·- targe t attachmen t. 
T his study //las sll]J]J0/1"d by Ih e N atiolla! SciCllcc COllllci! 'if the Repllb!ic of C hilla 
research grallt NSC 83-0412- B-037- 005 . 
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